A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT00077857 · COMPLETED
Trial details
- NCT number
- NCT00077857
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2010-03-01
- Enrollment
- 470
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.